Ballentine Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,939
Closed -$220K 1071
2025
Q3
$220K Sell
4,939
-62
-1% -$2.97K ﹤0.01% 868
2025
Q2
$240K Buy
+5,001
New +$218K ﹤0.01% 794
2025
Q1
Sell
-5,255
Closed -$241K 982
2024
Q4
$241K Buy
+5,255
New +$235K ﹤0.01% 702

Other funds holding QGEN

Ballentine Partners's QGEN Position: Q4 2025 in Review

Ballentine Partners sold out of Qiagen (QGEN) in Q4 2025, closing a stake of 4,939 shares — an estimated $220K sold.

Ballentine Partners first reported a position in QGEN in Q4 2024 and held it in 3 quarters. The position peaked at $241K in Q4 2024. 321 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.

  • Ballentine Partners reported no remaining Qiagen position as of Q4 2025 after selling out during the quarter.
  • Ballentine Partners sold 4,939 Qiagen shares in Q4 2025, an estimated $220K.
  • Ballentine Partners first reported a position in Qiagen in Q4 2024 and held it in 3 quarters.
  • Ballentine Partners's Qiagen position peaked at $241K in Q4 2024.
  • 321 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.

Based on Ballentine Partners's 13F filing for Q4 2025, filed 3 Feb 2026.